Clinical Trials Directory

Trials / Completed

CompletedNCT03319524

Clinical and Genetic Testing of Patients With Usher Syndrome

Prospective Open Label Clinical and Genetic Testing of Patients With Usher Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Sensor Technology for Deafblind · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is aimed to characterize Russian population of Usher patients.

Detailed description

This study is aimed to characterize Russian population of Usher patients. Tasks: Stage 1. Formation of the primary cohort of patients. Patients pre-recruiting will be performed based on Deaf-Blind Support Foundation "Con-nection" patient database analysis. Patients with clinically confirmed Usher syndrome will be evaluated according to available data of the clinical examination. Stage 2. Clinical examination of patients. Each patient will undergo the following diagnostic procedures according to the unified protocol: * Visometry (with correction and without correction) * Ophthalmoscopy * Perimetry * Optical coherence tomography * Electroretinography * Visually evoked potentials * Refractometry * Pneumotonometry * Biomicroscopy * Tonal audiometry * Electronic audiometry (ASSR test) * Acoustic impedance measurement * Vestibulometry * Electronystagmography * Any additional examinations and consultations if necessary Medical record will be developed and maintained for each patient consisting results of extended clinical examination. Stage 3. Genetic study of patients. All enrolled patients will undergo single 4 ml peripheral venous blood sampling. DNA will be extracted from leucocytes. DNA samples will be analyzed and placed for long-term storage in liquid nitrogen. Statistical and bioinformatic analysis of detected genetic mutations in the study cohort will be performed.

Conditions

Timeline

Start date
2017-05-17
Primary completion
2018-04-01
Completion
2018-06-01
First posted
2017-10-24
Last updated
2019-04-03

Locations

6 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT03319524. Inclusion in this directory is not an endorsement.